Alpha-glucosidase inhibitor

Information about Alpha-glucosidase inhibitor

Alpha glucosidase is an intestinal brush border enzyme responsible for the hydrolysis of disaccharides which is necessary for the absorption of starch, dextrins and disaccharides. Inhibition of this enzyme causes malabsorption and slowing of absortion of carbohydrates and decreases the postprandial rise in blood glucose. These drugs may also increase the release of glucagon-like peptide-1 (GLP-1) which may contribute to their glucosing lowering effects. Alpha glucosidase inhibitors have been shown to be effective in improving glycemic control in type 2 diabetes.

FDA approval information for Alpha-glucosidase inhibitor

Two alpha glucosidase inhibitors have been approved for use in the United States, acarbose (Precose) in 1995 and miglitol (Glyset) in 1996. While these two agents have a similar mechanism of action, they have different chemical structures and pharmacokinetics. Acarbose is a modified bacterial enzyme that is not appreciably absorbed, while miglitol is a synthetic pseudopolysaccharide that is absorbed from the gastrointestinal tract. Both drugs are taken three times daily with meals (with the first bite) and cause mild carbohydrate malabsorption.

Side effects of Alpha-glucosidase inhibitor

Common side effects of both agents are flatulence, abdominal bloating and discomfort and diarrhea.

Liver toxicity of Alpha-glucosidase inhibitor

Acarbose which has little systemic absorption, has been clearly linked to rare instances of clinically apparent liver injury, while no specific instances of such injury have been attributed to miglitol. Antidiabetics

Alpha-Glucosidase Inhibitors
- Acarbose
- Miglitol
Incretin-Based Drugs
- Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
- Glucagon-Like Peptide-1 (GLP-1) Analogues
Insulin
Metformin
Metiglinide Analogues
- Nateglinide
- Repaglinide
Pramlintide
Sodium Glucose Cotransporter-2 (SGLT-2) Inhibitors
Sulfonylureas
- First Generation Sulfonylureas
  - Acetohexamide
  - Chlorpropamide
  - Tolazamide
  - Tolbutamide
- Second Generation Sulfonylureas
  - Gliclazide
  - Glimepiride
  - Glipizide
  - Glyburide (Glibenclamide)
Thiazolidinediones

This article is a stub related to pharmacology. You can help WikiMD by expanding it!

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Transform your life with W8MD's budget GLP-1 injections from $125.

W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:

- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.

NYC weight loss doctor appointments

Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.

Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC

Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.